首页 > 最新文献

Iranian Journal of Medical Microbiology最新文献

英文 中文
Cerebral Venous Thrombosis (CVT) Following COVID-19 Vaccination: an Umbrella Review of Systematic Reviews COVID-19疫苗接种后脑静脉血栓形成(CVT):系统综述综述
Q4 Medicine Pub Date : 2023-01-01 DOI: 10.30699/ijmm.17.1.7
K. Shahsavarinia, G. Faridaalaee, H. Soleimanpour, Fatemeh Sadeghi-Ghyassi, Sanam Atashgahi, Nooshin Milanchian, N. Abolhasanpour, H. Salehi-pourmehr
{"title":"Cerebral Venous Thrombosis (CVT) Following COVID-19 Vaccination: an Umbrella Review of Systematic Reviews","authors":"K. Shahsavarinia, G. Faridaalaee, H. Soleimanpour, Fatemeh Sadeghi-Ghyassi, Sanam Atashgahi, Nooshin Milanchian, N. Abolhasanpour, H. Salehi-pourmehr","doi":"10.30699/ijmm.17.1.7","DOIUrl":"https://doi.org/10.30699/ijmm.17.1.7","url":null,"abstract":"","PeriodicalId":14580,"journal":{"name":"Iranian Journal of Medical Microbiology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42728720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Ventilator Associated Tracheobronchitis – Etiology and Outcome at an Intensive Care Unit of a Tertiary Care Center in North India 呼吸机相关性气管支气管炎——北印度一家三级护理中心重症监护室的病因和结果
Q4 Medicine Pub Date : 2023-01-01 DOI: 10.30699/ijmm.17.1.103
B. Kakati, Nupur Koul, S. Agarwal
{"title":"Ventilator Associated Tracheobronchitis – Etiology and Outcome at an Intensive Care Unit of a Tertiary Care Center in North India","authors":"B. Kakati, Nupur Koul, S. Agarwal","doi":"10.30699/ijmm.17.1.103","DOIUrl":"https://doi.org/10.30699/ijmm.17.1.103","url":null,"abstract":"","PeriodicalId":14580,"journal":{"name":"Iranian Journal of Medical Microbiology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45537295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anti-Mycobacterium tuberculosis Effects of Folk Medicinal Plants in Iran: A Mini-Systematic Review 伊朗民间药用植物抗结核分枝杆菌作用的系统评价
Q4 Medicine Pub Date : 2023-01-01 DOI: 10.30699/ijmm.17.1.1
R. Ramazanzadeh, Abdorazagh Marzban, Javad Khalili Fard Ardali, Reza Saki, H. Esmaeil Lashgarian, P. Shakib
{"title":"Anti-Mycobacterium tuberculosis Effects of Folk Medicinal Plants in Iran: A Mini-Systematic Review","authors":"R. Ramazanzadeh, Abdorazagh Marzban, Javad Khalili Fard Ardali, Reza Saki, H. Esmaeil Lashgarian, P. Shakib","doi":"10.30699/ijmm.17.1.1","DOIUrl":"https://doi.org/10.30699/ijmm.17.1.1","url":null,"abstract":"","PeriodicalId":14580,"journal":{"name":"Iranian Journal of Medical Microbiology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45590396","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and Multi-Drug Resistance Patterns of Uropathogenic E.coli isolated from Women Patients in Kirkuk city, Iraq 伊拉克基尔库克市女性患者尿路致病性大肠杆菌的流行率和多药耐药模式
Q4 Medicine Pub Date : 2022-10-01 DOI: 10.30699/ijmm.16.6.609
T. Fakhraddin Raheem, Sarah Ahmed Hasan Ali
{"title":"Prevalence and Multi-Drug Resistance Patterns of Uropathogenic E.coli isolated from Women Patients in Kirkuk city, Iraq","authors":"T. Fakhraddin Raheem, Sarah Ahmed Hasan Ali","doi":"10.30699/ijmm.16.6.609","DOIUrl":"https://doi.org/10.30699/ijmm.16.6.609","url":null,"abstract":"","PeriodicalId":14580,"journal":{"name":"Iranian Journal of Medical Microbiology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47579022","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of Circulating MicroRNA-222 in Patients with Chronic Hepatitis B virus Infection as a Potential Noninvasive Diagnostic Biomarker 慢性乙型肝炎病毒感染患者循环MicroRNA-222作为潜在的无创诊断生物标志物的评估
Q4 Medicine Pub Date : 2022-10-01 DOI: 10.30699/ijmm.16.6.543
F. Mokhtari, H. Kaboosi, S. Mohebbi, H. Asadzadeh Aghdaei, M. Zali
{"title":"Evaluation of Circulating MicroRNA-222 in Patients with Chronic Hepatitis B virus Infection as a Potential Noninvasive Diagnostic Biomarker","authors":"F. Mokhtari, H. Kaboosi, S. Mohebbi, H. Asadzadeh Aghdaei, M. Zali","doi":"10.30699/ijmm.16.6.543","DOIUrl":"https://doi.org/10.30699/ijmm.16.6.543","url":null,"abstract":"","PeriodicalId":14580,"journal":{"name":"Iranian Journal of Medical Microbiology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47319096","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A molecular New Update on the Biofilm Production and Carbapenem Resistance Mechanisms in Clinical Pseudomonas aeruginosa Isolates 铜绿假单胞菌临床分离株生物膜生成及碳青霉烯耐药机制的分子研究进展
Q4 Medicine Pub Date : 2022-10-01 DOI: 10.30699/ijmm.16.6.557
Raziyeh Ramazani, Rabeeh Izadi Amoli, Mojtaba Taghizadeh Armaki, Abazar Pournajaf, H. Kaboosi
{"title":"A molecular New Update on the Biofilm Production and Carbapenem Resistance Mechanisms in Clinical Pseudomonas aeruginosa Isolates","authors":"Raziyeh Ramazani, Rabeeh Izadi Amoli, Mojtaba Taghizadeh Armaki, Abazar Pournajaf, H. Kaboosi","doi":"10.30699/ijmm.16.6.557","DOIUrl":"https://doi.org/10.30699/ijmm.16.6.557","url":null,"abstract":"","PeriodicalId":14580,"journal":{"name":"Iranian Journal of Medical Microbiology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42924895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of High Level Aminoglycoside Resistance and Vancomycin Resistance in Enterococcal Isolates at A Tertiary Care Hospital 某三甲医院肠球菌分离株中高水平氨基糖苷类耐药性和万古霉素耐药性的患病率
Q4 Medicine Pub Date : 2022-09-01 DOI: 10.30699/ijmm.16.5.472
Dimple Raina, Anjali Negi, A. Pandita, N. Rawat
Background and Aim: Vancomycin resistant Enterococci (VRE) and high level aminoglycoside resistant (HLAR) Enterococci have complicated the available treatment modalities for Enterococci worldwide. The existing study was planned to evaluate the occurrence of HLAR and VRE strains in a tertiary care center in India and to study the association of HLAR with vancomycin sensitive Enterococci (VSE) and VRE. Materials and Methods: A total of 50 enterococcal isolates from various clinical specimens were incorporated in the study. Speciation was done on the basis of standard biochemical tests. HLAR was tested by the disc diffusion method using 150µg gentamicin disc and 200 µg streptomycin discs. Vancomycin susceptibility patterns were reported using vancomycin disc and agar dilution methods. Results & Conclusion: Pus samples comprised of the majority for the isolation of enterococcal strains (40%). 54% isolated strains were HLGR, 32% were HLSR and 14% isolates were positive for both HLGR and HLSR. 61.7% of Enterococcus faecium isolates demonstrated resistance for high-level gentamicin (HLGR) and 43.75% Enterococcus faecalis isolates were resistant to high-level streptomycin (HLSR). When VRE was compared to VSE, the rate of HLSR was detected to be 4.64% in VRE, while it was 32.55% in VSE; the rate of HLGR was noted to be 11.62% in VRE and it was 41.87% in VSE. The association of HLGR with HLSR (HLAR) was 2.32% in VRE and 13.95% in VSE strains. Enterococci strains are showing an increase in their antimicrobial resistance patterns. The increment of such strains in health care settings has to be reserved and controlled to avert complicated infections.
背景和目的:万古霉素耐药肠球菌(VRE)和高水平氨基糖苷类耐药肠球菌(HLAR)使世界范围内可用的肠球菌治疗方式变得复杂。现有研究计划评估印度三级护理中心HLAR和VRE菌株的发生情况,并研究HLAR与万古霉素敏感肠球菌(VSE)和VRE的关系。材料和方法:本研究共纳入来自不同临床标本的50株肠球菌分离株。特殊化是在标准生化测试的基础上进行的。HLAR通过椎间盘扩散法进行测试,使用150µg庆大霉素椎间盘和200µg链霉素椎间盘。使用万古霉素圆盘和琼脂稀释法报告了万古霉素的易感性模式。结果与结论:Pus样品用于分离肠球菌菌株占大多数(40%)。54%的分离株为HLGR,32%为HLSR,14%的分离株同时为HLGR和HLSR阳性。61.7%的粪肠球菌分离株对高水平庆大霉素(HLGR)具有耐药性,43.75%的粪肠球菌菌株对高水平链霉素(HLSR)具有耐药性。当将VRE与VSE进行比较时,在VRE中检测到HLSR的发生率为4.64%,而在VSE中为32.55%;VRE的HLGR发生率为11.62%,VSE为41.87%。HLGR与HLSR(HLAR)的相关性在VRE中为2.32%,在VSE菌株中为13.95%。肠球菌菌株的抗微生物耐药性正在增加。必须保留和控制此类菌株在卫生保健环境中的增加,以避免复杂的感染。
{"title":"Prevalence of High Level Aminoglycoside Resistance and Vancomycin Resistance in Enterococcal Isolates at A Tertiary Care Hospital","authors":"Dimple Raina, Anjali Negi, A. Pandita, N. Rawat","doi":"10.30699/ijmm.16.5.472","DOIUrl":"https://doi.org/10.30699/ijmm.16.5.472","url":null,"abstract":"Background and Aim: Vancomycin resistant Enterococci (VRE) and high level aminoglycoside resistant (HLAR) Enterococci have complicated the available treatment modalities for Enterococci worldwide. The existing study was planned to evaluate the occurrence of HLAR and VRE strains in a tertiary care center in India and to study the association of HLAR with vancomycin sensitive Enterococci (VSE) and VRE. Materials and Methods: A total of 50 enterococcal isolates from various clinical specimens were incorporated in the study. Speciation was done on the basis of standard biochemical tests. HLAR was tested by the disc diffusion method using 150µg gentamicin disc and 200 µg streptomycin discs. Vancomycin susceptibility patterns were reported using vancomycin disc and agar dilution methods. Results & Conclusion: Pus samples comprised of the majority for the isolation of enterococcal strains (40%). 54% isolated strains were HLGR, 32% were HLSR and 14% isolates were positive for both HLGR and HLSR. 61.7% of Enterococcus faecium isolates demonstrated resistance for high-level gentamicin (HLGR) and 43.75% Enterococcus faecalis isolates were resistant to high-level streptomycin (HLSR). When VRE was compared to VSE, the rate of HLSR was detected to be 4.64% in VRE, while it was 32.55% in VSE; the rate of HLGR was noted to be 11.62% in VRE and it was 41.87% in VSE. The association of HLGR with HLSR (HLAR) was 2.32% in VRE and 13.95% in VSE strains. Enterococci strains are showing an increase in their antimicrobial resistance patterns. The increment of such strains in health care settings has to be reserved and controlled to avert complicated infections.","PeriodicalId":14580,"journal":{"name":"Iranian Journal of Medical Microbiology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49503504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Possible Psychological Consequences in Public of Omicron Variant (B. 1.1. 529) of SARS-CoV-2 Identification in Iran 基因组变异对公众可能产生的心理影响(B. 1.1)。在伊朗鉴定SARS-CoV-2
Q4 Medicine Pub Date : 2022-09-01 DOI: 10.30699/ijmm.16.5.485
Omid Karimdadi Sariani, Amin Sadeghi dousari, Majid Taati Moghadam
For the first, Omicron variants (B. 1.1. 529) of SARS-CoV-2 emerged in Botswana and South Africa, which probably compromised vaccine effectiveness and the protective capability of antibodies released via infection of former variants. A study confirmed live Omicron virus still required ACE2 to infect human cells. Public concerns were raised due to abundant mutations in the spike protein and elsewhere on the Omicron variant resulting in an escape from vaccine-elicited immunity. Besides that, multiple mutations in the receptor-binding domain and S2 affect the affinity of viruses for human ACE2 and transmissibility (1). Shortly after introducing this variant, it was identified in different countries of Europe, Asia, and other parts of the world. Some centuries such as Japan and Israel, quickly closed their borders to foreign travelers due to fear of this deadly virus. To slow the spread of the variant, the UK government re-enforced the use of the mask in schools, public transport, and shops and quarantined all travelers and people in contact with an Omicron patient for 10 days. © 2022. This is an original open-access article distributed under the terms of the Creative Commons Attribution-noncommercial 4.0 International License which permits copy and redistribution of the material just in noncommercial usages with proper citation.
首先,Omicron变体(B. 1.1)。SARS-CoV-2在博茨瓦纳和南非出现,这可能降低了疫苗的有效性和通过感染前变体释放的抗体的保护能力。一项研究证实,活的欧米克隆病毒仍然需要ACE2才能感染人类细胞。由于刺突蛋白和Omicron变体的其他地方的大量突变导致逃避疫苗引起的免疫,引起了公众的关注。此外,受体结合域和S2的多个突变会影响病毒对人类ACE2的亲和力和传播性(1)。在引入该变体后不久,在欧洲、亚洲和世界其他地区的不同国家发现了该变体。几个世纪以来,由于担心这种致命病毒,日本和以色列等国迅速关闭了对外国游客的边境。为了减缓这种变异的传播,英国政府在学校、公共交通工具和商店重新强制使用口罩,并对所有旅行者和与欧米克隆患者接触过的人进行了10天的隔离。©2022。这是一篇原创的开放获取文章,在知识共享署名-非商业4.0国际许可协议的条款下发布,该协议允许复制和再分发材料,仅用于非商业用途,并附有适当的引用。
{"title":"Possible Psychological Consequences in Public of Omicron Variant (B. 1.1. 529) of SARS-CoV-2 Identification in Iran","authors":"Omid Karimdadi Sariani, Amin Sadeghi dousari, Majid Taati Moghadam","doi":"10.30699/ijmm.16.5.485","DOIUrl":"https://doi.org/10.30699/ijmm.16.5.485","url":null,"abstract":"For the first, Omicron variants (B. 1.1. 529) of SARS-CoV-2 emerged in Botswana and South Africa, which probably compromised vaccine effectiveness and the protective capability of antibodies released via infection of former variants. A study confirmed live Omicron virus still required ACE2 to infect human cells. Public concerns were raised due to abundant mutations in the spike protein and elsewhere on the Omicron variant resulting in an escape from vaccine-elicited immunity. Besides that, multiple mutations in the receptor-binding domain and S2 affect the affinity of viruses for human ACE2 and transmissibility (1). Shortly after introducing this variant, it was identified in different countries of Europe, Asia, and other parts of the world. Some centuries such as Japan and Israel, quickly closed their borders to foreign travelers due to fear of this deadly virus. To slow the spread of the variant, the UK government re-enforced the use of the mask in schools, public transport, and shops and quarantined all travelers and people in contact with an Omicron patient for 10 days. © 2022. This is an original open-access article distributed under the terms of the Creative Commons Attribution-noncommercial 4.0 International License which permits copy and redistribution of the material just in noncommercial usages with proper citation.","PeriodicalId":14580,"journal":{"name":"Iranian Journal of Medical Microbiology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42981216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Evaluation of the Presence of Gene Encoding Loa22 in Pathogenic Leptospira Serovars 致病性钩端螺旋体血清型中编码lo22基因的存在性评价
Q4 Medicine Pub Date : 2022-09-01 DOI: 10.30699/ijmm.16.5.392
Yeganeh Malek Mohammadi, P. Khaki, S. Moradi Bidhendi, M. Noofeli
Background and Aim: Leptospirosis is one of the most common zoonotic diseases worldwide, occurring mostly in tropical, subtropical, temperate, and humid regions with heavy rainfall. It is important to diagnose this condition correctly and promptly. Loa22 is an outer membrane protein exposed to the surface in some Leptospira serovars. The purpose of this study was to determine the presence of the gene encoding Loa22 protein in Leptospira interrogans serovars. Materials and Methods: The present study was conducted on 23 pathogenic leptospira serovars and two non-pathogenic leptospira serovars. These serovars were prepared from the Reference Laboratory for Leptospira, Department of Microbiology, Razi Vaccine, and Serum Research Institute, Karaj, Iran. After genomic DNA extraction using the standard phenol-chloroform method, loa22 gene was amplified by specific primers. Results: PCR was performed on the loa22 gene by producing a 671-bp fragment. The results showed that the loa22 gene was present in all 23 pathogenic leptospira serovars but not in the non-pathogenic L. biflexa . The specificity of tested primers was confirmed as well. Conclusion: The loa22 gene is a specific gene for pathogenic leptospira serovars that is not found in saprophytic serovars, so it is suggested that this gene be used to detect leptospira pathogenic serovars.
背景与目的:钩端螺旋体病是世界范围内最常见的人畜共患疾病之一,主要发生在热带、亚热带、温带和多雨的潮湿地区。正确、及时地诊断这种情况很重要。Loa22是暴露在一些钩端螺旋体血清型表面的外膜蛋白。本研究的目的是确定编码Loa22蛋白的基因在询问型钩端螺旋体血清型中的存在。材料与方法:对23种致病性钩端螺旋体血清型和2种非致病性钩体血清型进行研究。这些血清型是从钩端螺旋体参考实验室、Razi疫苗微生物学系和伊朗卡拉杰血清研究所制备的。用标准苯酚-三氯甲烷法提取loa22基因,用特异性引物扩增loa22。结果:对loa22基因进行了PCR扩增,得到671bp的片段。结果表明,loa22基因在所有23个致病性钩端螺旋体血清型中均存在,而在非致病性双弯乳杆菌中不存在。测试引物的特异性也得到了证实。结论:loa22基因是致病性钩端螺旋体血清型的特异性基因,在腐生型血清型中没有发现,因此建议利用该基因检测钩端螺旋病毒致病性血清型。
{"title":"Evaluation of the Presence of Gene Encoding Loa22 in Pathogenic Leptospira Serovars","authors":"Yeganeh Malek Mohammadi, P. Khaki, S. Moradi Bidhendi, M. Noofeli","doi":"10.30699/ijmm.16.5.392","DOIUrl":"https://doi.org/10.30699/ijmm.16.5.392","url":null,"abstract":"Background and Aim: Leptospirosis is one of the most common zoonotic diseases worldwide, occurring mostly in tropical, subtropical, temperate, and humid regions with heavy rainfall. It is important to diagnose this condition correctly and promptly. Loa22 is an outer membrane protein exposed to the surface in some Leptospira serovars. The purpose of this study was to determine the presence of the gene encoding Loa22 protein in Leptospira interrogans serovars. Materials and Methods: The present study was conducted on 23 pathogenic leptospira serovars and two non-pathogenic leptospira serovars. These serovars were prepared from the Reference Laboratory for Leptospira, Department of Microbiology, Razi Vaccine, and Serum Research Institute, Karaj, Iran. After genomic DNA extraction using the standard phenol-chloroform method, loa22 gene was amplified by specific primers. Results: PCR was performed on the loa22 gene by producing a 671-bp fragment. The results showed that the loa22 gene was present in all 23 pathogenic leptospira serovars but not in the non-pathogenic L. biflexa . The specificity of tested primers was confirmed as well. Conclusion: The loa22 gene is a specific gene for pathogenic leptospira serovars that is not found in saprophytic serovars, so it is suggested that this gene be used to detect leptospira pathogenic serovars.","PeriodicalId":14580,"journal":{"name":"Iranian Journal of Medical Microbiology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43655724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Retrospective Cross-sectional Survey on Urinary Tract Infections in a Non-hospital Medical Laboratory 非医院医学实验室尿路感染的回顾性横断面调查
Q4 Medicine Pub Date : 2022-09-01 DOI: 10.30699/ijmm.16.5.465
H. Sadeghi, N. Gheibi, F. Karimi Dermani, Saeideh Gholamzadeh Khoei
Background and Aim: Urinary tract infections (UTIs) that influence millions of humans yearly are still among the most common infections in the community and hospitals. This study aimed to investigate the prevalence of UTIs and their antibiotic resistance susceptibility in patients in Qazvin province, northwest Iran, from 2017 to 2019. Materials and Methods: This study was conducted on 3521 urine samples of patients referred to a non-hospital medical laboratory (Mehr) between April 2017 and January 2019. Samples were collected and processed immediately for laboratory analysis. Biochemical tests were conducted the bacteria identification, and the antibiotic susceptibility test of the bacterial isolates was determined using Kirby-Bauer disc diffusion. Results & Conclusion: 347 of the 3521 urine samples had significant bacteriuria, with a prevalence of 9.9 %. Escherichia coli occurred more frequently (54.4 %), while Pseudomonas aeruginosa had the lowest frequency of occurrence (1.4 %) in the samples. Nitrofurantoin and Amikacin were the most effective antibiotics against gram-negative and positive, respectively. This study revealed that bacterial resistance in UTIs continues to be a great problem and needs drug resistance surveillance periodically.
背景和目的:每年影响数百万人的尿路感染(UTIs)仍然是社区和医院中最常见的感染之一。本研究旨在调查2017年至2019年伊朗西北部卡兹温省患者尿路感染的患病率及其抗生素耐药性。材料和方法:本研究对2017年4月至2019年1月期间转诊至非医院医学实验室(Mehr)的3521名患者的尿液样本进行了研究。立即采集并处理样本进行实验室分析。生化试验进行细菌鉴定,并用Kirby-Bauer纸片扩散法测定分离菌株的抗生素敏感性。结果与结论:3521份尿样中347份有明显菌尿,检出率为9.9%。大肠杆菌的出现频率更高(54.4%),而铜绿假单胞菌的出现频率最低(1.4%)。呋喃妥因和阿米卡星分别是对革兰氏阴性和阳性最有效的抗生素。这项研究表明,尿路感染的细菌耐药性仍然是一个大问题,需要定期监测耐药性。
{"title":"A Retrospective Cross-sectional Survey on Urinary Tract Infections in a Non-hospital Medical Laboratory","authors":"H. Sadeghi, N. Gheibi, F. Karimi Dermani, Saeideh Gholamzadeh Khoei","doi":"10.30699/ijmm.16.5.465","DOIUrl":"https://doi.org/10.30699/ijmm.16.5.465","url":null,"abstract":"Background and Aim: Urinary tract infections (UTIs) that influence millions of humans yearly are still among the most common infections in the community and hospitals. This study aimed to investigate the prevalence of UTIs and their antibiotic resistance susceptibility in patients in Qazvin province, northwest Iran, from 2017 to 2019. Materials and Methods: This study was conducted on 3521 urine samples of patients referred to a non-hospital medical laboratory (Mehr) between April 2017 and January 2019. Samples were collected and processed immediately for laboratory analysis. Biochemical tests were conducted the bacteria identification, and the antibiotic susceptibility test of the bacterial isolates was determined using Kirby-Bauer disc diffusion. Results & Conclusion: 347 of the 3521 urine samples had significant bacteriuria, with a prevalence of 9.9 %. Escherichia coli occurred more frequently (54.4 %), while Pseudomonas aeruginosa had the lowest frequency of occurrence (1.4 %) in the samples. Nitrofurantoin and Amikacin were the most effective antibiotics against gram-negative and positive, respectively. This study revealed that bacterial resistance in UTIs continues to be a great problem and needs drug resistance surveillance periodically.","PeriodicalId":14580,"journal":{"name":"Iranian Journal of Medical Microbiology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46753586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Iranian Journal of Medical Microbiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1